Outcomes of Atherectomy and Balloon Angioplasty Compared to Conventional Angioplasty in Infra-popliteal Chronic Limb-Threatening Ischemia
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Chronic limb-threatening ischemia (CLTI) represents the most advanced stage of peripheral artery disease (PAD), characterized by rest pain, non-healing ulcers, or gangrene, and is associated with high morbidity and risk of amputation if left untreated. Infra-popliteal arteries are frequently involved in CLTI, especially in diabetic and elderly patients, posing significant challenges due to diffuse, calcified, and long-segment occlusive lesions. Conventional balloon angioplasty remains a first-line endovascular treatment but is limited by high restenosis and vessel recoil rates. Atherectomy, a plaque debulking technique, aims to improve luminal gain and vessel compliance prior to angioplasty, potentially enhancing outcomes in heavily calcified lesions. The combination of atherectomy and balloon angioplasty has shown promise in reducing dissection rates and improving technical success, yet its superiority over conventional angioplasty alone remains controversial. Given the growing use of endovascular therapies, a comparative analysis of outcomes between combined atherectomy-balloon angioplasty and conventional angioplasty in infra-popliteal interventions is essential to guide evidence-based management in CLTI patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2025
CompletedFirst Posted
Study publicly available on registry
August 13, 2025
CompletedStudy Start
First participant enrolled
September 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
ExpectedAugust 13, 2025
August 1, 2025
3 months
July 16, 2025
August 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
• Compare the 12-month primary patency rate between the two groups.
12 months
Study Arms (2)
atherectomy + balloon angioplasty
EXPERIMENTALconventional balloon angioplasty
EXPERIMENTALInterventions
Conventional balloon angioplasty remains a first-line endovascular treatment but is limited by high restenosis and vessel recoil rates. Atherectomy, a plaque debulking technique, aims to improve luminal gain and vessel compliance prior to angioplasty, potentially enhancing outcomes in heavily calcified lesions. The combination of atherectomy and balloon angioplasty has shown promise in reducing dissection rates and improving technical success, yet its superiority over conventional angioplasty alone remains controversial.
Percutaneous transluminal angioplasty of infra-popliteal arteries lesions with primary long
Eligibility Criteria
You may qualify if:
- All patients present with CLTI due to isolated infra-popliteal disease with the following criteria:
- Denovo or Recoil
- Reference tibial vessel diameter at least (2mm)
- The diseased tibial artery has a patent distal segment supplying the foot
You may not qualify if:
- Patients present with:
- Previous ipsilateral infrapopliteal bypass surgery
- Concomitant iliac or femoral artery lesion
- Isolated pedal arch disease
- previous atherectomy
- Faliure to cross the lesion
- Known hypercoagulable disorder or non-atherosclerotic vasculopathy
- Severe renal insufficiency (eGFR \<30) not on dialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer
Study Record Dates
First Submitted
July 16, 2025
First Posted
August 13, 2025
Study Start
September 30, 2025
Primary Completion
December 30, 2025
Study Completion (Estimated)
December 30, 2027
Last Updated
August 13, 2025
Record last verified: 2025-08